CVS Health (CVS) Tops Q4 EPS by 6c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
CVS Health Reports Fourth Quarter And Full-Year 2020 Results And Provides 2021 Full Year Guidance
February 16, 2021 6:30 AM ESTWOONSOCKET, R.I., Feb. 16, 2021 /PRNewswire/ --
Full Year and Fourth Quarter Highlights:
Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year Full year and fourth quarter GAAP diluted earnings per share from continuing operations of $5.47 and $0.75 Full year and fourth quarter Adjusted EPS of $7.50 and $1.30 Generated full year cash flow from operations of $15.9 billion Results reflect COVID-19 impacts and related investments2021 Full Year Guidance:
GAAP diluted EPS from continuing... More